Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

moksha8 Pharmaceuticals Inc.

www.moksha8.com

Latest From moksha8 Pharmaceuticals Inc.

AstraZeneca’s Ajay Gautam On Innovation From Emerging Markets: An Interview With PharmAsia News (Part 2 of 2)

AstraZeneca Head of Emerging Market Collaborations Ajay Gautam talks to PharmAsia News about the company’s R&D strategy and deals with local partners.

BioPharmaceutical China

AstraZeneca’s Ajay Gautam On Innovation From Emerging Markets: An Interview With PharmAsia News (Part 1 of 2)

AstraZeneca Head of Emerging Market Collaborations Ajay Gautam talks to PharmAsia News about the company’s R&D strategy and deals with local partners.

BioPharmaceutical China

Biopharma Dealmaking Quarterly Statistics, Q4 2012

At $4.2 billion, biopharma financing in Q4 2012 showed a 36% increase over Q3 with FOPOs again dominating as the most popular deal type. With 34 finalized biopharma M&As, Q4 was the most active quarter of all 2012 for acquisitions. The 108 biopharma alliances completed had a combined potential deal value of almost $2 billion; Johnson & Johnson, with seven tie-ups, was the busiest pharmaco during Q4.

BioPharmaceutical Deals

Emerging Views On Emerging Markets: Credit Suisse Healthcare Conference

PharmAsia News takes a closer look at presentations by Baxter, Forest, J&J, Novartis and Zimmer.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • South America
      • Brazil
  • Parent & Subsidiaries
  • moksha8 Pharmaceuticals Inc.
  • Senior Management
  • Simba Gill, PhD, Pres. & CEO
    Alex Howarth, CFO
    Alex Martin, SVP, Corp. Dev.
  • Contact Info
  • moksha8 Pharmaceuticals Inc.
    Phone: 11 3041 9300
    Av. Ibirapuera, 2332
    Tower 1,13th Fl
    São Paulo, 04028-002
    Brazil
Advertisement
Advertisement
UsernamePublicRestriction

Register